Empfehlungen zum Management der aneurysmatischen Subarachnoidalblutung

A. Raabe; J. Beck; J. Berkefeld; W. Deinsberger; J. Meixensberger; P. Schmiedek; V. Seifert; H. Steinmetz; A. Unterberg; P. Vajkoczy; C. Werner

doi:10.1055/s-2005-836479

Zentralblatt für Neurochirurgie, Table of Contents

Cent Eur Neurosurg 2005; 66(2): 79-91
DOI: 10.1055/s-2005-836479

Consensus Statement

Empfehlungen zum Management der aneurysmatischen Subarachnoidalblutung

Sektion vaskuläre Neurochirurgie der Deutschen Gesellschaft für Neurochirurgie und Wissenschaftlicher Arbeitskreis Neuroanästhesie der Deutschen Gesellschaft für Anästhesiologie und IntensivmedizinRecommendations for the Management of Patients with Aneurysmal Subarachnoid HemorrhageA. Raabe¹ , J. Beck¹ , J. Berkefeld² , W. Deinsberger³ , J. Meixensberger⁴ , P. Schmiedek⁵ , V. Seifert¹ , H. Steinmetz⁶ , A. Unterberg⁷ , P. Vajkoczy⁵ , C. Werner⁸

¹Klinik und Poliklinik für Neurochirurgie, Klinikum der Johann-Wolfgang-Goethe-Universität Frankfurt am Main, Germany
²Institut für Neuroradiologie, Klinikum der Johann-Wolfgang-Goethe-Universität Frankfurt am Main, Germany
³Neurochirurgische Klinik, Universitätsklinikum Gießen, Germany
⁴Neurochirurgische Klinik, Universität Leipzig, Germany
⁵Neurochirurgische Klinik, Klinikum Mannheim, Germany
⁶Klinik für Neurologie, Klinikum der Johann-Wolfgang-Goethe-Universität Frankfurt am Main, Germany
⁷Neurochirurgische Klinik, Ruprecht-Karls-Universität Heidelberg, Germany
⁸Klinik für Anästhesiologie, Klinikum der Johannes-Gutenberg-Universität Mainz, Germany

Abstract

Zusammenfassung

Die aneurysmatische Subarachnoidalblutung ist ein Krankheitsbild, das durch häufige primäre und sekundäre Komplikationen gekennzeichnet ist, die neurochirurgischen Interventionen bedürfen, um eine sekundäre Hirnschädigung zu vermeiden. Es ist Ziel der vorliegenden Arbeit, den aktuellen Stand der Datenlage für die einzelnen Therapiemodalitäten der Subarachnoidalblutung wiederzugeben, die im Rahmen des stationären Managements zur Anwendung kommen. Soweit möglich, erfolgt dabei eine Abstufung der Therapieempfehlungen entsprechend der Kriterien der evidenzbasierten Medizin. Die vorliegenden Empfehlungen wurden gemeinsam von der Sektion vaskuläre Neurochirurgie der Deutschen Gesellschaft für Neurochirurgie und dem Wissenschaftlichen Arbeitskreis Neuroanästhesie der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin erarbeitet.

Abstract

After SAH, primary and secondary complications are frequent and often require neurosurgical interventions to avoid secondary brain damage. The authors of the present paper have summarized the available data about the treatment modalities often used for patients with SAH. The present recommendations have been developed as a neurosurgical and neuroanestesiological consensus. Evidence from prospective, randomized, double blind, placebo-controlled studies support grade A recommendations (standard) for the prophylaxis and treatment of cerebral vasospasm with oral Nimodipine in good grade patients. For intravenous Nimodipine or for oral nimodipine treatment in poor grade patients, available data only support grade C recommendations (options). Despite the lack of data supporting standards (grade A) or guidelines (grade B), avoidance and rigorous treatment of hypotension and hypovolemia remains the mainstay in the prophylaxis and treatment of a delayed ischemic neurological deficit (DIND). Prophylactic hypervolemia or prophylactic hypertension and hypervolemia was shown to be ineffective in reducing symptomatic vasospasm and improving outcome (grade B). Therapeutic hypertensive hypervolemic hemodilution is recommended as a treatment of symptomatic vasospasm but no prospective studies are available (grade C recommendation). Suggested target values for moderate triple-H-therapy are CPP 80- 120 mmHg (MAP 90-130), CVP > 7 mmHg and Hk 0.25-0.40. Balloon angioplasty should be considered for treatment of DIND cause by focal, proximal cerebral vasospasm. There is no evidence supporting the routine use of antifibrinolytica, steroids or anticonvulsive prophylaxis. Clinical data indicate that current prophylaxis and treatment of cerebral vasospasm is still insufficient and aggressive triple-H-therapy is associated with an increased incidence of complications.

Schlüsselwörter

Subarachnoidalblutung - Reblutung - Vasospasmus - Triple-H-Therapie - Outcome - Aneurysma

Key words

subarachnoid hemorrhage - rebleeding - cerebral vasospasm - triple-H-therapy

Full Text

References

Literatur

1 The Brain Trauma Foundation, The American Association of Neurological Surgeons, The Joint Section on Neurotrauma and Critical Care . Role of antiseizure prophylaxis following head injury. J Neurotrauma. 2000; 17 549-553
2 The Brain Trauma Foundation, The American Association of Neurological Surgeons, The Joint Section on Neurotrauma and Critical Care . Role of steroids. J Neurotrauma. 2000; 17 531-535
3 Adams H P, Brott T G, Crowell R M, Furlan A J, Gomez C R, Grotta J, Helgason C M, Marler J R, Woolson R F, Zivin J A. Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1994; 25 1901-1914
4 Agnelli G, Piovella F, Buoncristiani P, Severi P, Pini M, D'Angelo A, Beltrametti C, Damiani M, Andrioli G C, Pugliese R, Iorio A, Brambilla G. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med. 1998; 339 80-85
5 Alberti O, Becker R, Benes L, Wallenfang T, Bertalanffy H. Initial hyperglycemia as an indicator of severity of the ictus in poor-grade patients with spontaneous subarachnoid hemorrhage. Clin Neurol Neurosurg. 2000; 102 78-83
6 Amin-Hanjani S, Schwartz R B, Sathi S, Stieg P E. Hypertensive encephalopathy as a complication of hyperdynamic therapy for vasospasm: report of two cases. Neurosurgery. 1999; 44 1113-1116
7 Awad I A, Carter L P, Spetzler R F, Medina M, Williams F C. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke. 1987; 18 365-372
8 Baker C J, Prestigiacomo C J, Solomon R A. Short-term perioperative anticonvulsant prophylaxis for the surgical treatment of low-risk patients with intracranial aneurysms. Neurosurgery. 1995; 37 863-870
9 Barker F G, Ogilvy C S. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg. 1996; 84 405-414
10 Beck J, Raabe A, Lanfermann H, Seifert V, Weidauer S. Tissue at risk concept for endovascular treatment of severe vasospasm after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2004; 75 1779-1181
11 Bederson J B, Awad I A, Wiebers D O, Piepgras D, Haley E C, Brott T, Hademenos G, Chyatte D, Rosenwasser R, Caroselli C. Recommendations for the management of patients with unruptured intracranial aneurysms: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2000; 31 2742-2750
12 Bejjani G K, Bank W O, Olan W J, Sekhar L N. The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery. 1998; 42 979-986
13 Bidzinski J, Marchel A, Sherif A. Risk of epilepsy after aneurysm operations. Acta Neurochir (Wien). 1992; 119 49-52
14 Biller J, Godersky J C, Adams H P. Management of aneurysmal subarachnoid hemorrhage. Stroke. 1988; 19 1300-1305
15 Black P M. Hydrocephalus and vasospasm after subarachnoid hemorrhage from ruptured intracranial aneurysms. Neurosurgery. 1986; 18 12-16
16 Brilstra E H, Rinkel G J, Algra A, van Gijn J. Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage. Neurology. 2000; 55 1656-1660
17 Broderick J P, Brott T G, Duldner J E, Tomsick T, Leach A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke. 1994; 25 1342-1347
18 Buchanan K M, Elias L J, Goplen G B. Differing perspectives on outcome after subarachnoid hemorrhage: the patient, the relative, the neurosurgeon. Neurosurgery. 2000; 46 831-838
19 Butzkueven H, Evans A H, Pitman A, Leopold C, Jolley D J, Kaye A H, Kilpatrick C J, Davis S M. Onset seizures independently predict poor outcome after subarachnoid hemorrhage. Neurology. 2000; 55 1315-1320
20 Claassen J, Peery S, Kreiter K T, Hirsch L J, Du E Y, Connolly E S, Mayer S A. Predictors and clinical impact of epilepsy after subarachnoid hemorrhage. Neurology. 2003; 60 208-214
21 Corsten L, Raja A, Guppy K, Roitberg B, Misra M, Alp M S, Charbel F, Debrun G, Ausman J. Contemporary management of subarachnoid hemorrhage and vasospasm: the UIC experience. Surg Neurol. 2001; 56 140-148
22 Coyne T J, Montanera W J, Macdonald R L, Wallace M C. Percutaneous transluminal angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Can J Surg. 1994; 37 391-396
23 Dammert S, Krings T, Moller-Hartmann W, Ueffing E, Hans F J, Willmes K, Mull M, Thron A. Detection of intracranial aneurysms with multislice CT: comparison with conventional angiography. Neuroradiology. 2004; 46 427-434
24 Dickinson L D, Miller L D, Patel C P, Gupta S K. Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors [In Process Citation]. Neurosurgery. 1998; 43 1074-1081
25 Diringer M N, Wu K C, Verbalis J G, Hanley D F. Hypervolemic therapy prevents volume contraction but not hyponatremia following subarachnoid hemorrhage. Ann Neurol. 1992; 31 543-550
26 du Mesnil D R, Heindel W, Wesselmann C, Kruger K, Lanfermann H, Ernestus R I, Neveling M, Lackner K. Nontraumatic subarachnoid hemorrhage: value of repeat angiography. Radiology. 1997; 202 798-800
27 Egge A, Waterloo K, Sjoholm H, Solberg T, Ingebrigtsen T, Romner B. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery. 2001; 49 593-605
28 Elliott J P, Newell D W, Lam D J, Eskridge J M, Douville C M, Le Roux P D, Lewis D H, Mayberg M R, Grady M S, Winn H R. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 1998; 88 277-284
29 Eskridge J M, McAuliffe W, Song J K, Deliganis A V, Newell D W, Lewis D H, Mayberg M R, Winn H R. Balloon angioplasty for the treatment of vasospasm: results of first 50 cases. Neurosurgery. 1998; 42 510-516
30 Eskridge J M, Newell D W, Pendleton G A. Transluminal angioplasty for treatment of vasospasm. Neurosurg Clin N Am. 1990; 1 387-399
31 Firlik A D, Kaufmann A M, Jungreis C A, Yonas H. Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 1997; 86 830-839
32 Foy P M, Chadwick D W, Rajgopalan N, Johnson A L, Shaw M D. Do prophylactic anticonvulsant drugs alter the pattern of seizures after craniotomy?. J Neurol Neurosurg Psychiatry. 1992; 55 753-757
33 Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Koike T, Tanaka R. Ultra-early rebleeding in spontaneous subarachnoid hemorrhage. J Neurosurg. 1996; 84 35-42
34 Gruber A, Reinprecht A, Bavinzski G, Czech T, Richling B. Chronic shunt-dependent hydrocephalus after early surgical and early endovascular treatment of ruptured intracranial aneurysms. Neurosurgery. 1999; 44 503-509
35 Hadeishi H, Mizuno M, Suzuki A, Yasui N. Hyperdynamic therapy for cerebral vasospasm. Neurol Med Chir (Tokyo). 1990; 30 317-323
36 Hanel R A, Xavier A R, Mohammad Y, Kirmani J F, Yahia A M, Qureshi A I. Outcome following intracerebral hemorrhage and subarachnoid hemorrhage. Neurol Res. 2002; 24 58-62
37 Haraguchi S, Ebina K. [Evaluation of the dopamine induced hypertension therapy for vasospasm (author's transl)]. No Shinkei Geka. 1982; 10 279-289
38 Hart R G, Byer J A, Slaughter J R, Hewett J E, Easton J D. Occurrence and implications of seizures in subarachnoid hemorrhage due to ruptured intracranial aneurysms. Neurosurgery. 1981; 8 417-421
39 Hasan D, Lindsay K W, Wijdicks E F, Murray G D, Brouwers P J, Bakker W H, van Gijn J, Vermeulen M. Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage. Stroke. 1989; 20 1156-1161
40 Hasan D, Vermeulen M, Wijdicks E F, Hijdra A, van Gijn J. Effect of fluid intake and antihypertensive treatment on cerebral ischemia after subarachnoid hemorrhage. Stroke. 1989; 20 1511-1515
41 Hasan D, Vermeulen M, Wijdicks E F, Hijdra A, van Gijn J. Management problems in acute hydrocephalus after subarachnoid hemorrhage. Stroke. 1989; 20 747-753
42 Hasan D, Wijdicks E F, Vermeulen M. Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. Ann Neurol. 1990; 27 106-108
43 Hayashi T, Hadeishi H, Kawamura S, Nonoyama Y, Suzuki A, Yasui N. Postoperative anticonvulsant prophylaxis for patients treated for cerebral aneurysms. Neurol Med Chir (Tokyo). 1999; 39 828-833
44 Heiskanen O, Poranen A, Kuurne T, Valtonen S, Kaste M. Acute surgery for intracerebral haematomas caused by rupture of an intracranial arterial aneurysm. A prospective randomized study. Acta Neurochir (Wien). 1988; 90 81-83
45 Higashida R T, Halbach V V, Cahan L D, Brant-Zawadzki M, Barnwell S, Dowd C, Hieshima G B. Transluminal angioplasty for treatment of intracranial arterial vasospasm. J Neurosurg. 1989; 71 648-653
46 Higashida R T, Halbach V V, Dowd C F, Dormandy B, Bell J, Hieshima G B. Intravascular balloon dilatation therapy for intracranial arterial vasospasm: patient selection, technique, and clinical results. Neurosurg Rev. 1992; 15 89-95
47 Hijdra A, Braakman R, van Gijn J, Vermeulen M, van Crevel H. Aneurysmal subarachnoid hemorrhage. Complications and outcome in a hospital population. Stroke. 1987; 18 1061-1067
48 Hijdra A, Vermeulen M, van Gijn J, van Crevel H. Rerupture of intracranial aneurysms: a clinicoanatomic study. J Neurosurg. 1987; 67 29-33
49 Hillman J. Should computed tomography scanning replace lumbar puncture in the diagnostic process in suspected subarachnoid hemorrhage?. Surg Neurol. 1986; 26 547-550
50 Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson K E. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg. 2002; 97 771-778
51 Hillman J, Essen C von, Leszniewski W, Johansson I. Significance of “ultra-early” rebleeding in subarachnoid hemorrhage. J Neurosurg. 1988; 68 901-907
52 Hop J W, Rinkel G J, Algra A, van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke. 1997; 28 660-664
53 Hop J W, Rinkel G J, Algra A, van Gijn J. Quality of life in patients and partners after aneurysmal subarachnoid hemorrhage. Stroke. 1998; 29 798-804
54 Hutter B O, Gilsbach J M. Which neuropsychological deficits are hidden behind a good outcome (Glasgow = I) after aneurysmal subarachnoid hemorrhage?. Neurosurgery. 1993; 33 999-1005
55 Inagawa T. Ultra-early rebleeding within six hours after aneurysmal rupture. Surg Neurol. 1994; 42 130-134
56 Inagawa T. Trends in incidence and case fatality rates of aneurysmal subarachnoid hemorrhage in Izumo City, Japan, between 1980-1989 and 1990-1998. Stroke. 2001; 32 1499-1507
57 Inagawa T, Kamiya K, Ogasawara H, Yano T. Rebleeding of ruptured intracranial aneurysms in the acute stage. Surg Neurol. 1987; 28 93-99
58 Ingall T, Asplund K, Mahonen M, Bonita R. A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study. Stroke. 2000; 31 1054-1061
59 Ingall T J, Whisnant J P, Wiebers D O, O'Fallon W M. Has there been a decline in subarachnoid hemorrhage mortality?. Stroke. 1989; 20 718-724
60 Iorio A, Agnelli G. Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis. Arch Intern Med. 2000; 160 2327-2332
61 Jakobsson K E, Saveland H, Hillman J, Edner G, Zygmunt S, Brandt L, Pellettieri L. Warning leak and management outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg. 1996; 85 995-999
62 Juvela S. Rebleeding from ruptured intracranial aneurysms. Surg Neurol. 1989; 32 323-326
63 Juvela S. Risk factors for multiple intracranial aneurysms. Stroke. 2000; 31 392-397
64 Karttunen A, Pyhtinen J, Tanska E L, Ronty H. Rupture of cerebral aneurysm during angiography. Neurochirurgia (Stuttg). 1986; 29 31-33
65 Kassell N F, Peerless S J, Durward Q J, Beck D W, Drake C G, Adams H P. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery. 1982; 11 337-343
66 Kassell N F, Torner J C. Aneurysmal rebleeding: a preliminary report from the Cooperative Aneurysm Study. Neurosurgery. 1983; 13 479-481
67 Kassell N F, Torner J C, Haley E C, Jane J A, Adams H P, Kongable G L. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg. 1990; 73 18-36
68 Katoh H, Shima K, Shimizu A, Takiguchi H, Miyazawa T, Umezawa H, Nawashiro H, Ishihara S, Kaji T, Makita K, Tsuchiya K. Clinical evaluation of the effect of percutaneous transluminal angioplasty and intra-arterial papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. Neurol Res. 1999; 21 195-203
69 Kawai K, Nagashima H, Narita K, Nakagomi T, Nakayama H, Tamura A, Sano K. Efficacy and risk of ventricular drainage in cases of grade V subarachnoid hemorrhage. Neurol Res. 1997; 19 649-653
70 Keranen T, Tapaninaho A, Hernesniemi J, Vapalahti M. Late epilepsy after aneurysm operations. Neurosurgery. 1985; 17 897-900
71 Kissela B M, Sauerbeck L, Woo D, Khoury J, Carrozzella J, Pancioli A, Jauch E, Moomaw C J, Shukla R, Gebel J, Fontaine R, Broderick J. Subarachnoid hemorrhage: a preventable disease with a heritable component. Stroke. 2002; 33 1321-1326
72 Komiyama M, Tamura K, Nagata Y, Fu Y, Yagura H, Yasui T. Aneurysmal rupture during angiography. Neurosurgery. 1993; 33 798-803
73 Kosnik E J, Hunt W E. Postoperative hypertension in the management of patients with intracranial arterial aneurysms. J Neurosurg. 1976; 45 148-154
74 Lanzino G, Kassell N F, Germanson T, Truskowski L, Alves W. Plasma glucose levels and outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg. 1993; 79 885-891
75 Lennihan L, Mayer S A, Fink M E, Beckford A, Paik M C, Zhang H, Wu Y C, Klebanoff L M, Raps E C, Solomon R A. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2000; 31 383-391
76 Levy M L, Day J D, Zelman V, Giannotta S L. Cardiac performance enhancement and hypervolemic therapy. Neurosurg Clin N Am. 1994; 5 725-739
77 Levy M L, Giannotta S L. Cardiac performance indices during hypervolemic therapy for cerebral vasospasm. J Neurosurg. 1991; 75 27-31
78 Levy M L, Rabb C H, Zelman V, Giannotta S L. Cardiac performance enhancement from dobutamine in patients refractory to hypervolemic therapy for cerebral vasospasm. J Neurosurg. 1993; 79 494-499
79 Linn F H, Rinkel G J, Algra A, van Gijn J. Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke. 1996; 27 625-629
80 Linn F H, Rinkel G J, Algra A, van Gijn J. The notion of “warning leaks” in subarachnoid haemorrhage: are such patients in fact admitted with a rebleed?. J Neurol Neurosurg Psychiatry. 2000; 68 332-336
81 Linn F H, Wijdicks E F, van der Graaf Y, Weerdesteyn-van Vliet F A, Bartelds A I, van Gijn J. Prospective study of sentinel headache in aneurysmal subarachnoid haemorrhage. Lancet. 1994; 344 590-593
82 Locksley H B. Natural history of subarachnoid hemorrhagem intracranial aneurysms and arteriovenous malformations. J Neurosurg. 1966; 25 321-368
83 Mallouhi A, Felber S, Chemelli A, Dessl A, Auer A, Schocke M, Jaschke W R, Waldenberger P. Detection and characterization of intracranial aneurysms with MR angiography: comparison of volume-rendering and maximum-intensity-projection algorithms. AJR Am J Roentgenol. 2003; 180 55-64
84 Mayberg M R, Batjer H H, Dacey R, Diringer M, Haley E C, Heros R C, Sternau L L, Torner J, Adams H P, Feinberg W. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1994; 25 2315-2328
85 Medlock M D, Dulebohn S C, Elwood P W. Prophylactic hypervolemia without calcium channel blockers in early aneurysm surgery [see comments]. Neurosurgery. 1992; 30 12-16
86 Mehta V, Holness R O, Connolly K, Walling S, Hall R. Acute hydrocephalus following aneurysmal subarachnoid hemorrhage. Can J Neurol Sci. 1996; 23 40-45
87 Meixensberger J, Vath A, Jaeger M, Kunze E, Dings J, Roosen K. Monitoring of brain tissue oxygenation following severe subarachnoid hemorrhage. Neurol Res. 2003; 25 445-450
88 Miller J A, Dacey R G, Diringer M N. Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage. Stroke. 1995; 26 2260-2266
89 Mitchell P, Wilkinson I D, Hoggard N, Paley M N, Jellinek D A, Powell T, Romanowski C, Hodgson T, Griffiths P D. Detection of subarachnoid haemorrhage with magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 2001; 70 205-211
90 Mori K, Arai H, Nakajima K, Tajima A, Maeda M. Hemorrheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 1995; 26 1620-1626
91 Mori T, Katayama Y, Kawamata T, Hirayama T. Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 1999; 91 947-952
92 Newell D W, Eskridge J M, Mayberg M R, Grady M S, Winn H R. Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg. 1989; 71 654-660
93 Nieuwkamp D J, de Gans K, Rinkel G J, Algra A. Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol. 2000; 247 117-121
94 Nilsson O G, Lindgren A, Stahl N, Brandt L, Saveland H. Incidence of intracerebral and subarachnoid haemorrhage in southern Sweden. J Neurol Neurosurg Psychiatry. 2000; 69 601-607
95 North J B, Penhall R K, Hanieh A, Hann C S, Challen R G, Frewin D B. Postoperative epilepsy: a double-blind trial of phenytoin after craniotomy. Lancet. 1980; 1 384-386
96 Nurmohamed M T, van Riel A M, Henkens C M, Koopman M M, Que G T, d'Azemar P, Buller H R, ten Cate J W, Hoek J A, van der Meer J, van der Heul C, Turpie A G, Haley S, Sicurella A, Gent M. Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery. Thromb Haemost. 1996; 75 233-238
97 O'Laoire S A. Epilepsy following neurosurgical intervention. Acta Neurochir Suppl (Wien). 1990; 50 52-54
98 Ohkuma H, Fujita S, Suzuki S. Incidence of aneurysmal subarachnoid hemorrhage in Shimokita, Japan, from 1989 to 1998. Stroke. 2002; 33 195-199
99 Ohkuma H, Tabata H, Suzuki S, Islam M S. Risk factors for aneurysmal subarachnoid hemorrhage in Aomori, Japan. Stroke. 2003; 34 96-100
100 Ohkuma H, Tsurutani H, Suzuki S. Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke. 2001; 32 1176-1180
101 Ohman J. Hypertension as a risk factor for epilepsy after aneurysmal subarachnoid hemorrhage and surgery. Neurosurgery. 1990; 27 578-581
102 Olafsson E, Gudmundsson G, Hauser W A. Risk of epilepsy in long-term survivors of surgery for aneurysmal subarachnoid hemorrhage: a population-based study in Iceland. Epilepsia. 2000; 41 1201-1205
103 Oliveira-Filho J, Ezzeddine M A, Segal A Z, Buonanno F S, Chang Y, Ogilvy C S, Rordorf G, Schwamm L H, Koroshetz W J, McDonald C T. Fever in subarachnoid hemorrhage: relationship to vasospasm and outcome. Neurology. 2001; 56 1299-1304
104 Origitano T C, Wascher T M, Reichman O H, Anderson D E. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution (“triple-H” therapy) after subarachnoid hemorrhage. Neurosurgery. 1990; 27 729-739
105 Oropello J M, Weiner L, Benjamin E. Hypertensive, hypervolemic, hemodilutional therapy for aneurysmal subarachnoid hemorrhage. Is it efficacious? No. Crit Care Clin. 1996; 12 709-730
106 Oskouian R J, Martin N A, Lee J H, Glenn T C, Guthrie D, Gonzalez N R, Afari A, Vinuela F. Multimodal quantitation of the effects of endovascular therapy for vasospasm on cerebral blood flow, transcranial Doppler ultrasonographic velocities, and cerebral artery diameters. Neurosurgery. 2002; 51 30-41
107 Otsubo H, Takemae T, Inoue T, Kobayashi S, Sugita K. Normovolaemic induced hypertension therapy for cerebral vasospasm after subarachnoid haemorrhage. Acta Neurochir (Wien). 1990; 103 18-26
108 Page R D, Richardson P L. Emergency surgery for haematoma-forming aneurysmal haemorrhage. Br J Neurosurg. 1990; 4 199-204
109 Pare L, Delfino R, Leblanc R. The relationship of ventricular drainage to aneurysmal rebleeding. J Neurosurg. 1992; 76 422-427
110 Pobereskin L H. Incidence and outcome of subarachnoid haemorrhage: a retrospective population based study. J Neurol Neurosurg Psychiatry. 2001; 70 340-343
111 Polin R S, Coenen V A, Hansen C A, Shin P, Baskaya M K, Nanda A, Kassell N F. Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2000; 92 284-290
112 Polin R S, Hansen C A, German P, Chadduck J B, Kassell N F. Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery. 1998; 42 1256-1264
113 Pritz M B, Giannotta S L, Kindt G W, McGillicuddy J E, Prager R L. Treatment of patients with neurological deficits associated with cerebral vasospasm by intravascular volume expansion. Neurosurgery. 1978; 3 364-368
114 Qureshi A I, Suri M F, Yahia A M, Suarez J I, Guterman L R, Hopkins L N, Tamargo R J. Risk factors for subarachnoid hemorrhage. Neurosurgery. 2001; 49 607-612
115 Raabe A, Beck J, Vatter H, Zimmermann M, Seifert V. Safety and efficacy of the different components of hemodynamic therapy in patients with symptomatic vasospasm. In: Macdonald RL (ed). Cerebral Vasospasm. Thieme, New York 2004; 243-246
116 Raabe A, Gerlach R, Zimmermann M, Seifert V. The risk of haemorrhage associated with early postoperative heparin administration after intracranial surgery. Acta Neurochir (Wien). 2001; 143 1-7
117 Rassias A J, Harbaugh R E, Corwin H L. Intra-abdominal hemorrhage complicating hypertensive therapy for cerebral vasospasm. Crit Care Med. 1995; 23 775-777
118 Rhoney D H, Tipps L B, Murry K R, Basham M C, Michael D B, Coplin W M. Anticonvulsant prophylaxis and timing of seizures after aneurysmal subarachnoid hemorrhage. Neurology. 2000; 55 258-265
119 Richardson A E, Uttley D. Prevention of postoperative epilepsy. Lancet. 1980; 1 650
120 Rinkel G J, Feigin V L, Algra A, Vermeulen M, van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2002; CD000277
121 Roos Y B, Beenen L F, Groen R J, Albrecht K W, Vermeulen M. Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery. J Neurol Neurosurg Psychiatry. 1997; 63 490-493
122 Roos Y B, Rinkel G J, Vermeulen M, Algra A, van Gijn J. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2000; CD001245
123 Rosenorn J, Eskesen V, Schmidt K, Ronde F. The risk of rebleeding from ruptured intracranial aneurysms. J Neurosurg. 1987; 67 329-332
124 Rosenwasser R H, Armonda R A, Thomas J E, Benitez R P, Gannon P M, Harrop J. Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery. 1999; 44 975-979
125 Rossi S, Zanier E R, Mauri I, Columbo A, Stocchetti N. Brain temperature, body core temperature, and intracranial pressure in acute cerebral damage. J Neurol Neurosurg Psychiatry. 2001; 71 448-454
126 Ruigrok Y M, Buskens E, Rinkel G J. Attributable risk of common and rare determinants of subarachnoid hemorrhage. Stroke. 2001; 32 1173-1175
127 Sarrafzadeh A, Haux D, Sakowitz O, Benndorf G, Herzog H, Kuechler I, Unterberg A. Acute focal neurological deficits in aneurysmal subarachnoid hemorrhage: Relation of clinical course, CT findings, and metabolite abnormalities monitored with bedside microdialysis. Stroke. 2003; 34 1382-1388
128 Sarti C, Tuomilehto J, Salomaa V, Sivenius J, Kaarsalo E, Narva E V, Salmi K, Torppa J. Epidemiology of subarachnoid hemorrhage in Finland from 1983 to 1985. Stroke. 1991; 22 848-853
129 Sbeih I, Tamas L B, O'Laoire S A. Epilepsy after operation for aneurysms. Neurosurgery. 1986; 19 784-788
130 Schuknecht B, Fandino J, Yuksel C, Yonekawa Y, Valavanis A. Endovascular treatment of cerebral vasospasm: assessment of treatment effect by cerebral angiography and transcranial colour Doppler sonography. Neuroradiology. 1999; 41 453-462
131 Sethi H, Moore A, Dervin J, Clifton A, MacSweeney J E. Hydrocephalus: comparison of clipping and embolization in aneurysm treatment. J Neurosurg. 2000; 92 991-994
132 Shaw M D, Foy P M. Epilepsy after craniotomy and the place of prophylactic anticonvulsant drugs: discussion paper. J R Soc Med. 1991; 84 221-223
133 Sheehan J P, Polin R S, Sheehan J M, Baskaya M K, Kassell N F. Factors associated with hydrocephalus after aneurysmal subarachnoid hemorrhage. Neurosurgery. 1999; 45 1120-1127
134 Shimoda M, Oda S, Tsugane R, Sato O. Intracranial complications of hypervolemic therapy in patients with a delayed ischemic deficit attributed to vasospasm. J Neurosurg. 1993; 78 423-429
135 Solenski N J, Haley E C, Kassell N F, Kongable G, Germanson T, Truskowski L, Torner J C. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med. 1995; 23 1007-1017
136 Srinivasan J, Moore A, Eskridge J, Winn H R, Newell D W. Long-term follow up of angioplasty for cerebral vasospasm. Acta Neurochir. 2001; 77 (Suppl) 195-197
137 Steiger H J, Fritschi J, Seiler R W. Current pattern of in-hospital aneurysmal rebleeds. Analysis of a series treated with individually timed surgery and intravenous nimodipine. Acta Neurochir (Wien). 1994; 127 21-26
138 Suarez-Rivera O. Acute hydrocephalus after subarachnoid hemorrhage. Surg Neurol. 1998; 49 563-565
139 Tapaninaho A, Hernesniemi J, Vapalahti M. Emergency treatment of cerebral aneurysms with large haematomas. Acta Neurochir (Wien). 1988; 91 21-24
140 Teunissen L L, Rinkel G J, Algra A, van Gijn J. Risk factors for subarachnoid hemorrhage: a systematic review. Stroke. 1996; 27 544-549
141 Tokuda Y, Inagawa T, Katoh Y, Kumano K, Ohbayashi N, Yoshioka H. Intracerebral hematoma in patients with ruptured cerebral aneurysms. Surg Neurol. 1995; 43 272-277
142 Tolias C M, Choksey M S. Will increased awareness among physicians of the significance of sudden agonizing headache affect the outcome of subarachnoid hemorrhage? Coventry and Warwickshire Study: audit of subarachnoid hemorrhage (establishing historical controls), hypothesis, campaign layout, and cost estimation. Stroke. 1996; 27 807-812
143 Torner J C, Davis P H. Epidemiology and clinical manifestations of subarachnoid hemorrhage. In: Bederson JB (ed). Subarachnoid Hemorrhage: Pathophysiology and Management. American Association of Neurological Surgeons, Park Ridge 1997; 1-26
144 Ullman J S, Bederson J B. Hypertensive, hypervolemic, hemodilutional therapy for aneurysmal subarachnoid hemorrhage. Is it efficacious? Yes. Crit Care Clin. 1996; 12 697-707
145 Vajkoczy P, Horn P, Bauhuf C, Munch E, Hubner U, Ing D, Thome C, Poeckler-Schoeninger C, Roth H, Schmiedek P. Effect of intra-arterial papaverine on regional cerebral blood flow in hemodynamically relevant cerebral vasospasm. Stroke. 2001; 32 498-505
146 Vajkoczy P, Horn P, Thome C, Munch E, Schmiedek P. Regional cerebral blood flow monitoring in the diagnosis of delayed ischemia following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003; 98 1227-1234
147 van Gijn J, Hijdra A, Wijdicks E F, Vermeulen M, van Crevel H. Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg. 1985; 63 355-362
148 van Gijn J, Rinkel G J. Subarachnoid haemorrhage: diagnosis, causes and management. Brain. 2001; 124 249-278
149 Vassilouthis J, Richardson A E. Ventricular dilatation and communicating hydrocephalus following spontaneous subarachnoid hemorrhage. J Neurosurg. 1979; 51 341-351
150 Voldby B, Enevoldsen E M. Intracranial pressure changes following aneurysm rupture. Part 3: Recurrent hemorrhage. J Neurosurg. 1982; 56 784-789
151 Weir B K, Kongable G L, Kassell N F, Schultz J R, Truskowski L L, Sigrest A. Cigarette smoking as a cause of aneurysmal subarachnoid hemorrhage and risk for vasospasm: a report of the Cooperative Aneurysm Study. J Neurosurg. 1998; 89 405-411
152 Whisnant J P, Sacco S E, O'Fallon W M, Fode N C, Sundt T M. Referral bias in aneurysmal subarachnoid hemorrhage. J Neurosurg. 1993; 78 726-732
153 Wiebers D O, Whisnant J P, Huston J, Meissner I, Brown R D, Piepgras D G, Forbes G S, Thielen K, Nichols D, O'Fallon W M, Peacock J, Jaeger L, Kassell N F, Kongable-Beckman G L, Torner J C. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003; 362 103-110
154 Wijdicks E F, Vermeulen M, Hijdra A, van Gijn J. Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful?. Ann Neurol. 1985; 17 137-140
155 Wijdicks E F, Vermeulen M, van Brummelen P, van Gijn J. The effect of fludrocortisone acetate on plasma volume and natriuresis in patients with aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg. 1988; 90 209-214
156 Zubkov A Y, Lewis A I, Scalzo D, Bernanke D H, Harkey H L. Morphological changes after percutaneous transluminal angioplasty. Surg Neurol. 1999; 51 399-403
157 Zubkov Y N, Nikiforov B M, Shustin V A. Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir (Wien). 1984; 70 65-79

Prof. Dr. med. Andreas Raabe

Klinik und Poliklinik für Neurochirurgie · Johann-Wolfgang-Goethe-Universität

Schleusenweg 2-16

60528 Frankfurt am Main

Germany

Phone: +49/69/63 01 59 39

Fax: +49/69/63 01 71 75

Email: A.Raabe@em.uni-frankfurt.de